BridgeMD
New treatment option for Ridge Augmentation
Official title One Stage Ridge Splitting Using 2 Different Techniques in the Posterior Mandible
ClinicalTrials.gov ID: NCT06891313
What this study is testing
- What it's testing
- The selected patients will be informed of the nature of the research work and informed consent will be obtained. The control group ridge splitting with simultaneous implants using the conventional technique and study group ridge splitting with simultaneous implants using the piezo surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 48
You may be able to join if
- Patients with mandibular residual alveolar bone height not less than 8 mm.
- Alveolar bone width from 5mm to 3mm.
- Both genders.
- At least single missing tooth.
- Previous failed implants.
You likely can't join if
- Heavy smokers more than 20 cigarettes per day.
- Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
- Patients had radiotherapy and chemotherapy in head and neck.
- Patients had neoplasms in sites to be grafted.
- Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
- Pregnant females.
See the full eligibility criteria
- Patients with mandibular residual alveolar bone height not less than 8 mm.
- Alveolar bone width from 5mm to 3mm.
- Both genders.
- At least single missing tooth.
- Previous failed implants.
- Tapered or cylinder cross sectioned alveolar bone defect pattern.
- Heavy smokers more than 20 cigarettes per day.
- Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
- Patients had radiotherapy and chemotherapy in head and neck.
- Patients had neoplasms in sites to be grafted.
- Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
- Pregnant females.
- Patients with Para functional habits, apprehensive and non-cooperative.
- Bone pathology related to the site to be grafted.
- Psychological problems, stress situation (socially or professionally), emotional instability, and unrealistic patients' expectations.
- Intraoral soft and hard tissue pathology.
- Systemic condition that contraindicates implant placement.
- Under the age of 18 years.
- Hourglass defects or defects with bone concavities and or undercuts.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 48 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.